Clinuvel is almost ending the financial year and I expect about 110 Mln AUD revenues. In line with growth over the past years. Profits should be up at the same rate too since they did not spend anything more on branding, marketing, raw materials or other things. They cut a lot of costs slashing the other trials. That means the cash pile should be getting closer to 250mln aud with interest flowing in at ever higher rates. As can be seen in the previous half year results that interest already forms a big part of the positive results. It's time to start using at least all interest for developing the business.
I presume they will buy new scenesse implants during the latter part of the year to have some stock again. After reading the half year results, I was under the impression they had not bought any over the July-Dec 24 period. They did not find it worthy to comment.
My sincere hope is they will increase the effort to find a new CEO. 3 months absence is already too much in this company defining year.
So that's it for 2025 than? Back to sleep or did I forget another milestone? yawn
CUV Price at posting:
$10.83 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)